Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntertek Group Regulatory News (ITRK)

Share Price Information for Intertek Group (ITRK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,744.00
Bid: 4,744.00
Ask: 4,748.00
Change: -146.00 (-2.99%)
Spread: 4.00 (0.084%)
Open: 4,884.00
High: 4,884.00
Low: 4,716.00
Prev. Close: 4,890.00
ITRK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition

19 Feb 2008 07:00

Intertek Group PLC19 February 2008 Intertek acquires CML Biotech Limited Intertek Group plc (Intertek), the leading international provider of quality andsafety services to a wide range of industries, announces the acquisition of CMLBiotech Limited (CML), the holding company for the Commercial MicrobiologyGroup, a microbiology testing laboratory and consulting business for the oil andgas industry. Intertek purchased CML from its management shareholders Dr Stephen Maxwell andJohn McCulloch for an initial cash consideration of GBP 8 million and deferredconsideration of approximately GBP 2 million payable in March 2009. CML provides laboratory and consultancy services and sells testing kitsrelated to the measurement and management of bacteria in the upstream oil andgas industry. The business supports oil and gas exploration companies inaddressing bacterial contamination of pipelines and infrastructure used duringproduction, storage, and extraction of oil and gas reserves. The integrity ofpipelines is affected by corrosion caused by bacteria. Bacterial and hygieneservices are also provided for drinking water supplied to offshore platforms and vessels. CML has a strong industry wide reputation for its expertise andexperience in this analytical services sector. While the majority of CML's operations are in the North Sea and Gulf of Mexicomarkets, CML also supports the other main oil and gas provinces, including Northand West Coast Africa, the Caspian Sea and the Middle East. These and other oilreserve regions present growth opportunities for CML and Intertek together. CML has 54 employees in total, based in Aberdeen, Scotland and in Houston, USA,and it will form part of Intertek's Analytical Services division. Wolfhart Hauser, Chief Executive Officer of Intertek, commented:"CML is a valuable addition to our upstream analytical services business. Thebusiness holds a very strong and impressive market position in microbialservices, which will expand the suite of expert services that we deliver as apartner to the oil & gas exploration industry globally". -ends-ContactsAston Swift / Sarah Ogilvie IntertekTelephone: +44 (0) 20 7396 3400aston.swift@intertek.com / sarah.ogilvie@intertek.com Richard Mountain / Sophie Kernon, Financial DynamicsTelephone: +44 (0) 20 7269 7121richard.mountain@fd.com / sophie.kernon@fd.com Notes to Editors From 1 January 2008, Intertek's Analytical Services, previously part of theGroup's Oil Chemical & Agri division, became a standalone division. For furtherdetails of this and the surrounding divisional re-organisation, refer toIntertek's stock exchange announcement of 11 December 2007. ABOUT INTERTEK Intertek (LSE: ITRK) is the leading international provider of quality and safetyservices to a wide range of global and local industries. Partnership withIntertek brings increased value to customers' products and processes, ultimatelysupporting their success in the global market place. Intertek has theexperience, expertise, resources and global reach to support its customersthrough itsextensive network of laboratories and offices, with over 20,000 people in morethan 100 countries around the world.www.intertek.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
6th Jun 201410:00 amRNSDirector/PDMR Shareholding
2nd Jun 20141:00 pmRNSTotal Voting Rights
21st May 20143:04 pmRNSBlocklisting Interim Review
21st May 20143:00 pmRNSBlocklisting Interim Review
16th May 20141:30 pmRNSResult of AGM
16th May 20141:22 pmRNSAGM Statement
16th May 20147:00 amRNSInterim Management Statement
1st May 20141:00 pmRNSTotal Voting Rights
29th Apr 20147:01 amRNSDirectorate Change
14th Apr 201410:17 amRNSHolding(s) in Company
3rd Apr 20143:30 pmRNSDirector/PDMR Shareholding
19th Mar 20147:00 amRNSAnnual Financial Report
11th Mar 20142:15 pmRNSDirector/PDMR Shareholding
11th Mar 20142:15 pmRNSDirector/PDMR Shareholding
11th Mar 201411:09 amRNSDirector/PDMR Shareholding
3rd Mar 20141:00 pmRNSTotal Voting Rights
3rd Mar 20147:02 amRNSAcquisition
3rd Mar 20147:00 amRNSAnnual Financial Report
3rd Feb 20141:00 pmRNSTotal Voting Rights
31st Jan 20142:30 pmRNSHolding(s) in Company
2nd Jan 20141:00 pmRNSTotal Voting Rights
13th Dec 20131:00 pmRNSHolding(s) in Company
21st Nov 20131:00 pmRNSBlocklisting Interim Review
21st Nov 20131:00 pmRNSBlocklisting Interim Review
21st Nov 20131:00 pmRNSBlocklisting Interim Review
19th Nov 20137:00 amRNSAcquisition
19th Nov 20137:00 amRNSInterim Management Statement
1st Nov 20131:00 pmRNSTotal Voting Rights
14th Oct 20131:00 pmRNSHolding(s) in Company
3rd Oct 20137:00 amRNSAcquisition
1st Oct 20131:00 pmRNSTotal Voting Rights
24th Sep 20134:00 pmRNSHolding(s) in Company
2nd Sep 20131:00 pmRNSHolding(s) in Company
2nd Sep 20131:00 pmRNSTotal Voting Rights
28th Aug 20137:00 amRNSDirectorate Change
2nd Aug 20133:00 pmRNSDirector Declaration
1st Aug 20131:00 pmRNSTotal Voting Rights
29th Jul 20137:00 amRNSHalf Yearly Report
9th Jul 20137:00 amRNSAcquisition
1st Jul 20131:00 pmRNSTotal Voting Rights
5th Jun 20132:00 pmRNSHolding(s) in Company
3rd Jun 20134:04 pmRNSTotal Voting Rights
21st May 20132:30 pmRNSHolding(s) in Company
21st May 20132:30 pmRNSBlocklisting Interim Review
21st May 20132:30 pmRNSBlocklisting Interim Review
21st May 20132:30 pmRNSBlocklisting Interim Review
20th May 20132:30 pmRNSDirector/PDMR Shareholding
20th May 20132:15 pmRNSHolding(s) in Company
17th May 20132:00 pmRNSResult of AGM
17th May 20131:37 pmRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.